Role of Serum Prolactin Levels in Meningitis
Serum prolactin has no established role in the diagnosis or management of meningitis and should not be measured for this purpose. The current evidence-based guidelines and research do not support the use of prolactin as a diagnostic or prognostic biomarker in meningitis.
Standard Diagnostic Approach to Meningitis
The diagnosis of meningitis relies on established markers that have been validated through extensive research and guideline development:
Primary Diagnostic Tests
CSF analysis remains the gold standard for diagnosing meningitis, with the following strongly recommended parameters 1:
- CSF leukocyte count (Grade A recommendation)
- CSF protein concentration (Grade A recommendation)
- CSF glucose concentration and CSF:plasma glucose ratio (Grade A recommendation)
- CSF Gram stain and culture (Grade A recommendation)
Serum Inflammatory Markers with Established Utility
When differentiating between bacterial and viral meningitis, the following serum markers have demonstrated clinical value:
C-reactive protein (CRP):
- In children, CRP >40 mg/L shows 93% sensitivity and 100% specificity for bacterial meningitis 1
- However, CRP has limited value when other bacterial infections (sepsis, pneumonia) are in the differential diagnosis 1
Procalcitonin (PCT):
- Serum PCT is the most validated serum biomarker for differentiating bacterial from viral meningitis 2
- In adults, serum PCT >10.2 ng/mL demonstrates sensitivity and specificity up to 100% for bacterial meningitis 2
- In children, using a cutoff of 15.0 mg/L, PCT shows 94% sensitivity and 100% specificity 2
- PCT should be used as an adjunct to standard CSF analysis, not in isolation 2
Blood Cultures
Blood cultures should be obtained before antibiotic administration (Grade A recommendation) 1:
- Positive in 75% of pneumococcal meningitis cases
- Positive in 50-90% of H. influenzae meningitis cases
- Positive in 40-60% of meningococcal meningitis cases 1
Why Prolactin Is Not Recommended
The comprehensive ESCMID guidelines on acute bacterial meningitis diagnosis explicitly state that "a plethora of studies have assessed whether individual CSF chemokine, cytokine, complement factors and metabolite levels" could be useful, but "few markers were replicated in independent cohorts or compared to the test characteristics of the marker to standard diagnostics tests" 1. These experimental markers, which would include prolactin if it had been studied, "may be valuable for pathophysiologic research but so far have not reached implementation in a clinical setting" 1.
Practical Clinical Algorithm
When evaluating a patient with suspected meningitis:
- Immediately obtain blood cultures before antibiotics 1, 2
- Perform lumbar puncture (unless contraindicated) and send CSF for:
- Cell count with differential
- Protein and glucose (with simultaneous serum glucose)
- Gram stain and culture
- Consider CSF lactate (good sensitivity/specificity for bacterial vs. aseptic meningitis) 1
- Obtain serum procalcitonin as an adjunct marker 2
- Do NOT delay antibiotic treatment while waiting for any test results 2
- Do NOT measure serum prolactin - it has no validated role
Common Pitfalls to Avoid
- Do not use serum inflammatory markers alone to diagnose bacterial meningitis, as they can be elevated in other bacterial infections 1
- Do not rely on procalcitonin in isolation to determine whether to initiate antimicrobial therapy 2
- Do not order unvalidated biomarkers like prolactin, as they waste resources and may delay appropriate management
- Remember that CSF parameters can be atypical in neonates, partially treated patients, and certain pathogens (e.g., Listeria) 1